Symetryx Corp 13D and 13G filings for NeuBase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-20 5:28 pm Sale |
2023-09-14 | 13D | NeuBase Therapeutics, Inc. NBSE |
Symetryx Corp | 109,508 3.500% |
-363,418 (-76.84%) |
Filing |
| 2023-09-14 06:03 am Purchase |
2023-09-08 | 13D | NeuBase Therapeutics, Inc. NBSE |
Symetryx Corp | 472,926 9.100% |
44,482 (+10.38%) |
Filing |
| 2023-08-31 11:50 am Purchase |
2023-08-22 | 13D | NeuBase Therapeutics, Inc. NBSE |
Symetryx Corp | 428,444 13.800% |
428,444 (New Position) |
Filing |